Uterine neoplasms, version 3.2021: Featured updates to the NCCN guidelines Guidelines


Authors: Abu-Rustum, N. R.; Yashar, C. M.; Bradley, K.; Campos, S. M.; Chino, J.; Chon, H. S.; Chu, C.; Cohn, D.; Crispens, M. A.; Damast, S.; Diver, E.; Fisher, C. M.; Frederick, P.; Gaffney, D. K.; George, S.; Giuntoli, R. 2nd; Han, E.; Howitt, B.; Huh, W. K.; Lea, J.; Mariani, A.; Mutch, D.; Nekhlyudov, L.; Podoll, M.; Remmenga, S. W.; Reynolds, R. K.; Salani, R.; Sisodia, R.; Soliman, P.; Tanner, E.; Ueda, S.; Urban, R.; Wethington, S. L.; Wyse, E.; Zanotti, K.; McMillian, N. R.; Motter, A. D.
Title: Uterine neoplasms, version 3.2021: Featured updates to the NCCN guidelines
Abstract: The NCCN Guidelines for Uterine Neoplasms provide recommendations for diagnostic workup, clinical staging, and treatment options for patients with endometrial cancer or uterine sarcoma. These NCCN Guidelines Insights focus on the recent addition of molecular profiling information to aid in accurate diagnosis, classification, and treatment of uterine sarcomas. © National Comprehensive Cancer Network, Inc. 2021.
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 19
Issue: 8
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2021-08-01
Start Page: 889
End Page: 895
Language: English
DOI: 10.6004/jnccn.2021.0038
PROVIDER: scopus
PUBMED: 34416706
DOI/URL:
Notes: Review -- Export Date: 1 September 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work